Charles Schwab Investment Management Inc. Has $16.23 Million Position in Clarivate PLC $CLVT

Key Points

• Charles Schwab Investment Management Inc. reduced its stake in Clarivate PLC by 3.8%, selling 164,935 shares, and now owns 4,129,983 shares worth approximately $16.23 million.
• Vanguard Group Inc. and Truffle Hound Capital LLC increased their positions in Clarivate, with Vanguard acquiring an additional 218,938 shares, raising its stake by 2.5% during the same period.
• Following a recent earnings report, Clarivate maintained a guidance of 0.600-0.700 EPS for FY 2025, with analysts predicting an average EPS of 0.63 for the current year.

Charles Schwab Investment Management Inc. cut its position in shares of Clarivate PLC (NYSE:CLVT - Free Report) by 3.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,129,983 shares of the company's stock after selling 164,935 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.60% of Clarivate worth $16,231,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Tower Research Capital LLC TRC lifted its holdings in Clarivate by 34.9% in the fourth quarter. Tower Research Capital LLC TRC now owns 27,995 shares of the company's stock worth $142,000 after acquiring an additional 7,247 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of Clarivate by 3.8% during the 1st quarter. Bank of New York Mellon Corp now owns 2,429,086 shares of the company's stock worth $9,546,000 after buying an additional 88,670 shares in the last quarter. Atairos Partners GP Inc. acquired a new position in shares of Clarivate during the 4th quarter valued at $17,602,000. Deutsche Bank AG increased its holdings in shares of Clarivate by 27.4% in the fourth quarter. Deutsche Bank AG now owns 26,217 shares of the company's stock valued at $133,000 after buying an additional 5,641 shares in the last quarter. Finally, Invenomic Capital Management LP increased its stake in Clarivate by 11.3% in the 4th quarter. Invenomic Capital Management LP now owns 6,585,707 shares of the company's stock worth $33,455,000 after purchasing an additional 667,146 shares in the last quarter. 85.72% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CLVT. Jefferies Financial Group assumed coverage on Clarivate in a report on Friday, July 18th. They set a "hold" rating and a $4.50 price target on the stock. Wall Street Zen lowered shares of Clarivate from a "buy" rating to a "hold" rating in a research note on Saturday, June 21st. Three analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Clarivate has a consensus rating of "Reduce" and an average target price of $4.83.

Clarivate Stock Performance

Shares of NYSE CLVT traded down $0.01 during trading hours on Wednesday, hitting $4.47. 2,024,910 shares of the company's stock were exchanged, compared to its average volume of 5,590,359. The company's 50-day moving average price is $4.24 and its 200-day moving average price is $4.17. Clarivate PLC has a 1-year low of $3.04 and a 1-year high of $7.15. The stock has a market capitalization of $3.00 billion, a price-to-earnings ratio of -7.20 and a beta of 1.40. The company has a debt-to-equity ratio of 0.90, a current ratio of 0.91 and a quick ratio of 0.91.

Clarivate (NYSE:CLVT - Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $0.18 EPS for the quarter, meeting the consensus estimate of $0.18. The firm had revenue of $621.40 million during the quarter, compared to analysts' expectations of $587.17 million. Clarivate had a negative net margin of 17.33% and a positive return on equity of 8.65%. The business's quarterly revenue was down 4.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.20 EPS. Clarivate has set its FY 2025 guidance at 0.600-0.700 EPS. On average, sell-side analysts expect that Clarivate PLC will post 0.63 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider James Gordon Samson sold 100,000 shares of the company's stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $4.53, for a total value of $453,000.00. Following the sale, the insider directly owned 1,271,103 shares in the company, valued at approximately $5,758,096.59. This represents a 7.29% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 23.18% of the stock is currently owned by corporate insiders.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.